NEWSROOM

February 22, 2021

SHL Telemedicine announces it is exploring dual listing on another leading Stock Exchange in the US or on the Tel Aviv Stock Exchange

February 17, 2021

SHL Telemedicine closes second capital increase

February 16, 2021

SHL Telemedicine continues implementation of its strategic plan and expands the use of SmartHeart™ technology in the US. Key executives join the SHL US enterprise

January 25, 2021

SHL Telemedicine closed acquisition of Jumedi GmbH a developer of Digital Health technologies and strengthens leadership of its German operation

January 22, 2021

SHL announces invitation to a Special General Meeting for approval of an amendment to the terms of office of the Chairman of the Board and an amendment to the compensation policy of the Company

January 21, 2021

SHL Telemedicine closes first of two capital increases

January 12, 2021

SHL Telemedicine files pre-submission with FDA for Over the Counter clearance of SHL’s SmartHeart™ full 12 Lead ECG

January 12, 2021

SHL Telemedicine German operation receives notice, following a tender process, regarding discontinuation of a large Chronic Disease Telehealth contract

January 7, 2021

SHL Special General Meeting approves Increase of Capital and Amendment to Articles of Association